Improved adverse postoperative outcomes with revised American College of Cardiology/American Heart Association Guidelines for patients with cardiac stents

JAMA Surgery

Volumn 149, Issue 11, 2014, Pages 1113-1120

  Graham, Laura A ^a,b   Singletary, Brandon A ^a,b   Richman, Joshua S ^a,b   Maddox, Thomas M ^c,d   Itani, Kamal M F ^e,f   Hawn, Mary T ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b Kentucky   (United States)

^c Eastern Colorado Veterans Health Care System   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARE METAL STENT; CLINICAL EXAMINATION; DRUG ELUTING STENT; EMERGENCY WARD; FEMALE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PATIENT TRANSPORT; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; REVASCULARIZATION; RISK FACTOR; STATISTICAL MODEL; CONFIDENCE INTERVAL; ELECTIVE SURGERY; HEART ARREST; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA; TIME; TREATMENT OUTCOME; UNITED STATES; UTILIZATION;

AMERICAN HEART ASSOCIATION; CONFIDENCE INTERVALS; DRUG-ELUTING STENTS; ELECTIVE SURGICAL PROCEDURES; FEMALE; HEART ARREST; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84911375264     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.2044     Document Type: Article

References (23)

1. HawnMT, Graham LA, Richman JR, et al. The incidence and timing of noncardiac surgery after cardiac stent implantation. J AmColl Surg. 2012;214 (4):658-666.
2. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J AmColl Cardiol. 2007;50(17):1707-1732.
3. Anwaruddin S, Askari AT, Saudye H, et al. Characterization of post-operative risk associated with prior drug-eluting stent use. JACC Cardiovasc Interv. 2009;2(6):542-549.
4. HawnMT, Graham LA, Richman JS, Itani KM, HendersonWG, Maddox TM. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA. 2013;310(14): 1462-1472.
5. van Kuijk JP, FluWJ, Schouten O, et al. Timing of noncardiac surgery after coronary artery stenting with baremetal or drug-eluting stents. Am J Cardiol. 2009;104(9):1229-1234.
6. Devereaux PJ,Mrkobrada M, Sessler DI, et al; POISE-2 Investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014; 370(16):1494-1503.
7. Darvish-KazemS, Gandhi M, Marcucci M, Douketis JD. Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines. Chest. 2013; 144(6):1848-1856.
8. Harrell FE Jr. Regression Modeling Strategies With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer; 2001.
9. Wickham H. GGPLOT2: Elegant Graphics for Data Anlaysis. New York, NY: Springer; 2009.
10. Wood SN. Generalized Additive Models: An Introduction With R. New York, NY: Chapman & Hall/CRC; 2006.
11. Graham LA, Maddox TM, Itani KM, Hawn MT. Coronary stents and subsequent surgery: reported provider attitudes and practice patterns. Am Surg. 2013;79(5):514-523.
12. Sharma AK, Ajani AE, Hamwi SM, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv. 2004;63(2):141-145.
13. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364(9444):1519-1521.
14. Nasser M, Kapeliovich M, MarkiewiczW. Late thrombosis of sirolimus-eluting stents following noncardiac surgery. Catheter Cardiovasc Interv. 2005;65(4):516-519.
15. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. Am J Cardiol. 2005; 95(6):755-757.
16. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol. 2007;49(1):122-124.
17. Compton PA, Zankar AA, Adesanya AO, Banerjee S, Brilakis ES. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol. 2006;98(9):1212-1213.
18. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49(22):2145-2150.
19. Auerbach DI, Maeda JL, Steiner C. Hospital stays with cardiac stents, 2009. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb128.pdf. Accessed March 19, 2014.
20. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA. 2008;299(24):2868-2876.
21. Yeh RW, ChandraM,McCulloch CE, Go AS. Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study. BMC Med. 2011;9:78.
22. Huesch MD. External adjustment sensitivity analysis for unmeasured confounding: an application to coronary stent outcomes, Pennsylvania 2004-2008. Health Serv Res. 2013; 48(3):1191-1214.
23. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with baremetal stents: real or artefactual? Catheter Cardiovasc Interv. 2008;71(5): 636-643.